Trends in coagulase-negative staphylococci (CoNS), England, 2010-2021.
Author
Paranthaman, KarthikWilson, Allegra
Verlander, Neville
Rooney, Graeme
Macdonald, Neil
Nsonwu, Olisaeloka
Hope, Russell
Fleming, Paul
Hatcher, James
Ogundipe, Enitan
Wan, Yu
Pichon, Bruno
Westrop, Samantha J
Brown, Colin S
Demirjian, Alicia
Ratnaraja, Natasha

Publication date
2023-06-19Subject
Microbiology. Immunology
Metadata
Show full item recordAbstract
Overall, 668 857 episodes of CoNS were reported. Unspeciated CoNS accounted for 56 % (374 228) of episodes, followed by Staphylococcus epidermidis (26 %; 174 050), S. hominis (6.5 %; 43 501) and S. capitis (3.9 %; 25 773). Unspeciated CoNS increased by 8.2 % (95 % CI, 7.1-9.3) annually between 2010 and 2016, then decreased annually by 6.4 % (95 % CI: -4.8 to -7.9) until 2021. Speciated CoNS increased by 47.6 % (95 % CI, 44.5-50.9) annually between 2010 and 2016 and increased annually by 8.9 % (95 % CI: 5.1 to 12.8) until 2021. Antimicrobial susceptibility profiles differed by species.Citation
Paranthaman K, Wilson A, Verlander N, Rooney G, Macdonald N, Nsonwu O, Hope R, Fleming P, Hatcher J, Ogundipe E, Ratnaraja N, Wan Y, Pichon B, Westrop SJ, Brown CS, Demirjian A. Trends in coagulase-negative staphylococci (CoNS), England, 2010-2021. Access Microbiol. 2023 Jun 19;5(6):acmi000491.v3. doi: 10.1099/acmi.0.000491.v3.Type
ArticleAdditional Links
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323795/PMID
37424540Journal
Access MicrobiologyPublisher
Microbiology Societyae974a485f413a2113503eed53cd6c53
10.1099/acmi.0.000491.v3